Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival.
about
A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerWas there shortening of the interval between diagnosis and treatment of colorectal cancer in southern Netherlands between 2005 and 2008?Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series.Characteristics, survival, and related factors of newly diagnosed colorectal cancer patients refusing cancer treatments under a universal health insurance program.The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancerAssociations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk.The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG).The loss in expectation of life after colon cancer: a population-based studyMultidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice.Information provision and patient reported outcomes in patients with metastasized colorectal cancer: results from the PROFILES registry.Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening.Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient reported outcomes following initial treatment and long term evaluation of survivorship registry.Neo-adjuvant radiotherapy in rectal cancer.Treatment of colorectal cancer in older patients.Age-related systemic treatment and survival of patients with metachronous metastases from colorectal cancer.Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer.Progress in rectal cancer treatment.Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.Pattern of rectal cancer recurrence after curative surgery.Socioeconomic inequalities in relative survival of rectal cancer most obvious in stage III.Trends in colorectal incidence by anatomic subsite from 1985 to 2005: a population-based study.Combination chemotherapy with Regorafenib in metastatic colorectal cancer treatment: A single center, retrospective study.Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer.Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients.Radiological and pathological evaluation of the level of arterial division after colon cancer surgery.PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis.
P2860
Q26739607-D453BA29-F7F0-49B5-B7F1-69DA5F2C19AAQ33766383-D2CB472C-F85C-4459-89EC-35FC4B63C15DQ33777340-7A58E506-4F57-4930-8492-1215CD36EA0EQ33811632-7DCB0CCC-7C36-4F0D-87F0-416FC09AE57DQ34044158-8056CDA2-B55C-4BD8-B0CD-DB94ADE48355Q34221731-87916260-24BF-469F-B0F1-3AF1526E0D00Q34334152-C333C071-44EA-4EE6-AC5B-662282F71234Q35633808-463C7848-063D-44B0-A720-DBBA047C8CE6Q35920508-5783910E-3C7A-4FE2-897C-EB1FAD021C1DQ35925226-BCF1D9E1-8888-4F66-BA55-66E3E4DBF038Q36641556-9F0A4172-FBEB-4B98-8BAB-8061D468DC1EQ36745822-3E04BDDA-7D8B-41F6-8B57-54F7D9811692Q36758901-17A5F7E0-7750-4B01-9B67-CDDDF2E90859Q36914037-F3747EA3-C72A-400E-8EEF-7AEC9578A687Q37408813-0E5CF3B5-8979-4E51-A44D-9DDEB95AAA03Q38050375-4869835E-BF26-42F3-9202-CFA2A4192440Q38825369-9C1E942C-514D-4992-99B3-3CF153552A5AQ39442876-67491D5E-2AD0-4CC2-8EB7-F7FC51E2BD03Q39554319-765446CD-F342-46DE-9E18-26AFBF5E64B8Q40152954-91E49CAC-F124-4DD1-8BE7-5C9D45973295Q41183550-AC1E7AD8-A71A-44C9-A838-FCAF6AFA48D3Q43573009-7EF736B1-167D-4065-BF10-5EFC619EB4A0Q44812992-FA3B9169-7AC2-4982-B44A-494594F96063Q47179500-A0CE183C-C2FD-483B-82F2-BFA0F151817FQ47955155-E0A3A1C7-0877-405E-BED2-062D9583FF65Q50432002-E4CAA2F5-F287-43B3-8B20-9DD273307463Q50919391-DAB04288-31A0-4E01-A367-D9D619E9494AQ52809337-98398FD8-DA49-464B-AFCD-7588FD0AE72EQ54568696-7B833E10-9205-4E85-ACA0-0987A419ABD9
P2860
Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Trends in colorectal cancer in ...... ls with colon cancer survival.
@en
Trends in colorectal cancer in ...... ls with colon cancer survival.
@nl
type
label
Trends in colorectal cancer in ...... ls with colon cancer survival.
@en
Trends in colorectal cancer in ...... ls with colon cancer survival.
@nl
prefLabel
Trends in colorectal cancer in ...... ls with colon cancer survival.
@en
Trends in colorectal cancer in ...... ls with colon cancer survival.
@nl
P2093
P2860
P1433
P1476
Trends in colorectal cancer in ...... ls with colon cancer survival.
@en
P2093
Harm Rutten
Hendrik Martijn
Jan Willem Coebergh
Liza van Steenbergen
Maryska Janssen-Heijnen
Valery Lemmens
P2860
P304
P356
10.3109/02841861003733713
P577
2010-08-01T00:00:00Z